Long-term survival can be achieved in a significant fraction of older patients with core binding factor acute myeloid leukemia treated with intensive chemotherapy
Federico Mosna(Paracelsus Medical University), Michele Gottardi(Ca' Foncello Hospital), Nicolaus Kröger(Universität Hamburg), Anna Candoni(University of Udine), Peter Valent(Medical University of Vienna), H. Joachim Deeg(Fred Hutch Cancer Center), Moreno Festuccia(University of Turin), Elizabeth A. Morgan(Brigham and Women's Hospital), Alessandra Sperotto(Istituto Oncologico Veneto), Roberto Cairoli(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Mauro Krampera(University of Verona), Erika Borlenghi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Giuseppe Visani(Ospedali Riuniti Marche Nord), Sheeja T. Pullarkat(University of California, Los Angeles), Gerwin Huls(University Medical Center Groningen), Gian Matteo Rigolin, Felicetto Ferrara(San Antonio College), Carmela Gurrieri(University of Padua), Eros DiBona(Ospedale San Bortolo), Cristina Papayannidis(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Monia Lunghi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Gautam Borthakur(The University of Texas MD Anderson Cancer Center), Guido Marcucci(City of Hope), Debora Capelli(Ospedali Riuniti Umberto I), Cecilia C.S. Yeung(University of Washington), Jason Gotlib(Stanford University), Giovanni Roti(University of Parma), Cristina Tecchio(University of Verona), Francesco Albano(University of Bari Aldo Moro), Giovanni Martinelli(University of Bologna), Ann‐Kathrin Eisfeld, Ernesta Audisio(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Mark R. Litzow(Dana-Farber Cancer Institute), Denise Marvalle(Ospedale Maggiore), Adriano Venditti(University of Rome Tor Vergata), John C. Byrd(The Ohio State University), Fabio Forghieri(Azienda Ospedaliero-Universitaria di Modena), Francesco Lanza(University of Bologna), Sara Galimberti(University of Pisa)
Cited by 4
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k